Salivary glands provide the greatest diversity of histologic types and subtypes of primary tumors, 1 and of these glands, the parotid gland is more frequently affected by tumors. Parotid gland tumors account for approximately 3% of all head and neck tumors. Pleomorphic adenoma is the most common parotid neoplasm (70%), followed by Warthin's tumor and other malignancies. 2, 3 The possibility of malignancy should be ruled out in patients with any mass in the parotid gland to ensure proper management planning. This usually requires cytologic or histologic evaluation by fine needle aspiration biopsy or parotidectomy. [3] [4] [5] Preoperative MR imaging is useful for the evaluation of tumors and for surgical planning as it allows tumor locations to be assessed. In particular, dynamic contrast-enhanced (DCE) perfusion MR imaging has been reported to be useful tool Objectives: To identify diagnostically meaningful differences between Warthin's tumor and malignant masses in the parotid gland by dynamic susceptibility contrast (DSC) MR imaging Methods: Eleven malignant parotid tumors and 9 Warthin's tumors were included. MR imaging was performed on all patients. Signal intensity time curves of tumors were obtained by DSC MR imaging and dynamic susceptibility contrast percentages (DSC%) were calculated. Results: No significant difference was observed between malignant tumors and Warthin's tumors (P = 0.437), although DSC% values tended to be higher for Warthin's tumors. Conclusions: Warthin's tumor tended to have higher DSC% values than malignant parotid tumors, but this difference was not significantly different.
for the differentiation of salivary gland tumors. [6] [7] [8] [9] [10] [11] Perfusion MR imaging, which is sensitive to microvasculature, is performed with (dynamic susceptibility contrast imaging and DCE imaging) or without contrast agent (arterial spin labeling, i.e., ASL). 12 Dynamic susceptibility contrast (DSC) techniques are the most widely used method to measure brain perfusion by MR imaging. DSC perfusion MR imaging has relatively shorter imaging and data acquisition times than ASL, and DCE perfusion MR imaging also allows greater anatomical coverage. 12 DSC perfusion MR imaging measures signal loss during the passage of a bolus of non-diffusible contrast through a tumor, 13 and can be performed using the bolus tracking technique, which monitors the first passage of contrast medium through a capillary bed. DSC perfusion MR imaging is being increasingly used to assess the extents of capillaries and of the microvasculatures of various tumors in brain, liver, and breast, and as a diagnostic and research tool. DSC perfusion MR imaging is well suited for evaluating tumor angiogenesis since the degree of signal loss depends on the volume of the intravascular space within a tumor and on the concentration of injected contrast agent in blood, 14 and thus, it provides access to the physiology of microcirculation, especially of the microvasculature. 15 DSC perfusion MR imaging can be helpful for evaluating brain tumors and for differentiating benign and malignant tumors, 14 and has also been used to characterize and differentiate head and neck cancers. 10 In a previous study, which evaluated signal intensity ratios (SIRs) on ASL images of salivary gland tumors, mean SIRs were found to be significantly higher for Warthin's tumors than those of malignant tumors representing more perfusion of Warthin's tumors than malignant tumors. 9 However, other studies reported that Warthin's tumors represent more perfusion of malignant tumors than Warthin's tumors. 11, 16 These conflicting results mean that the differential diagnosis of Warthin's tumor and malignant parotid tumors is still difficult and has a debate. Warthin's tumors contain abundant blood vessels, an extensive capillary network, and many leaky blood vessels pathologically. 6 Thus, we wondered why Warthin's tumor had conflict perfusion compared with malignant parotid masses. Given the above background, we evaluated perfusion difference between Warthin's tumor and malignant parotid gland tumors on DSC perfusion MR image and reviewed the previous reports.
MATERIALS AND METHODS
This prospective study was approved by the hu- DSC% values were higher for Warthin's tumors (76.11 ± 20.29) ( Fig. 1 ) than malignant tumors (62.82 ± 12.03) (Fig. 2) . However, no significant difference was observed between Warthin's tumors and malignant tumors (P = 0.437) ( Fig. 3 ).
DISCUSSION
Perfusion MR imaging is non-invasive technique used to quantify brain perfusion and provides reliable values for cerebral blood flow, and has been reported to be useful tool for noninvasive assessments of tumor blood flow in patients with head and neck tumors. 17 Razek et al. reported that
Warthin's tumor showed lower perfusion than malignant parotid gland tumors or other head and neck malignancies. 10, 11 However, Kato et al. 9 ob- In conclusion, Warthin's tumor tended to have higher DSC% values than malignant parotid tu-
